🏛️ Verified NIH Record • Updated 2026-08-07
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections (NCT06827990)
Evaluation of the GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
🟢 Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: W.L.Gore & Associates
🩺 Plain-English Summary (8th-Grade Level)
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
Who can join: Review the eligibility criteria below.
Location: University of Alabama at Birmingham — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (22 Sites)
- University of Alabama at Birmingham — Birmingham, Alabama
- University of Southern California — Los Angeles, California
- The Stanford Hospital — Palo Alto, California
- University of Florida — Gainesville, Florida
- Emory University School of Medicine — Atlanta, Georgia
- Northwestern Medicine — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- Massachusetts General Hospital — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Corewell Health System — Grand Rapids, Michigan
- Washington University School of Medicine - St. Louis — St Louis, Missouri
- Hackensack Medical Center — Hackensack, New Jersey
- Westchester Medical Center — Westchester, New York
- Duke University Medical Center — Durham, North Carolina
- Cleveland Clinic — Cleveland, Ohio
- Ohio Health Research Institute — Columbus, Ohio
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- The Methodist Hospital Houston — Houston, Texas
- Baylor Research Institute — Plano, Texas
- WVU Medicine — Morgantown, West Virginia
- Medical College of Wisconsin — Milwaukee, Wisconsin
📞 Contact the Study Coordinator
Phone: (800) 437-8181
Email: ARISE3Pivotal@wlgore.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aortic Dissection
- Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE) — Stanford, California
- Hemiarch vs Extended Arch in Type 1 Aortic Dissection — London, Ontario
- NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness — Birmingham, Alabama
- Feasibility of Endovascular Repair Of Ascending Aortic Pathologies — Long Beach, California
Explore by condition: All Aortic Dissection clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.